We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CTI BioPharma Corporation | NASDAQ:CTIC | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.09 | 10.01 | 8.64 | 0 | 01:00:00 |
Washington
|
|
001-12465
|
|
91-1533912
|
(State or other jurisdiction of
incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification Number)
|
Exhibit No.
|
|
Description
|
10.1
|
|
Separation and Release Agreement, dated March 13, 2017, by and between the Company and Louis A. Bianco.
|
|
CTI BIOPHARMA CORP.
|
|
||||
|
|
|
|
|||
|
|
|
|
|||
|
|
|
|
|||
|
By:
|
/s/ Richard L. Love
|
|
|||
|
Date:
|
March 13, 2017
|
|
|
Name:
Richard L. Love
|
|
|
|
Title:
Interim President and Chief Executive Officer
|
|
Exhibit No.
|
|
Description
|
10.1
|
|
Separation and Release Agreement, dated March 13, 2017, by and between the Company and Louis A. Bianco.
|
1 Year CTI BioPharma Chart |
1 Month CTI BioPharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions